Zobrazeno 1 - 2
of 2
pro vyhledávání: '"van Scheppingen RH"'
Autor:
Scott JS; Center for Molecular Medicine, UMC Utrecht, Utrecht, The Netherlands., Al Ayadi L; Center for Molecular Medicine, UMC Utrecht, Utrecht, The Netherlands., Epeslidou E; Center for Molecular Medicine, UMC Utrecht, Utrecht, The Netherlands., van Scheppingen RH; Center for Molecular Medicine, UMC Utrecht, Utrecht, The Netherlands., Mukha A; Department of Medical BioSciences, RadboudUMC, Nijmegen, The Netherlands., Kaaij LJT; Center for Molecular Medicine, UMC Utrecht, Utrecht, The Netherlands., Lutz C; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Prekovic S; Center for Molecular Medicine, UMC Utrecht, Utrecht, The Netherlands. s.prekovic@umcutrecht.nl.
Publikováno v:
Oncogene [Oncogene] 2024 Nov 29. Date of Electronic Publication: 2024 Nov 29.
Autor:
Bornes L; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Scheppingen RH; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., Beerling E; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schelfhorst T; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ellenbroek SIJ; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., Seinstra D; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: d.seinstra@amsterdamumc.nl., van Rheenen J; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: j.v.rheenen@nki.nl.
Publikováno v:
Cell reports [Cell Rep] 2019 Nov 26; Vol. 29 (9), pp. 2565-2569.e3.